GCO — Genesco Inc. · 2026-09-06 · Verdict: WATCH · Conviction 3
Price $35.81 (universe_under2b.csv screen row built 2026-09-06, reflecting the 2026-09-04 close; no live quotes in this sandbox) · Mkt cap ~$386M (10.79M shares) · EV ~$345M · EV/EBIT 20.0x trailing, 8.6x on FY27 guidance · FCF yield 21.0% screened, ~6.1% adjusted · Net cash $41.3M · ADV $8.9M Sources read: 10-K 2026-03-25 (Items 1, 1A, 7), 10-Q 2026-06-11, DEF 14A 2025-05-16, 8-Ks 2026-05-05, 06-29, 07-22, 08-06, 09-03, Form 4s (12m), Q2 FY27 release and presentation 2026-09-03. No Q&A transcript available.
1. What the business actually does
Genesco is a Nashville footwear retailer and wholesaler founded in 1924, running 1,186 stores at 2026-08-01 across four segments (Q2 release). Journeys, Journeys Kidz and Little Burgundy sell branded fashion footwear to 13-to-22-year-olds and were 61% of Fiscal 2026 sales (10-K 2026, Item 1). Schuh does the same job in the UK and Ireland from 109 stores, 21% of sales, e-commerce over 45% of its own revenue. Johnston & Murphy, the one owned brand, is 13% of sales through 153 shops plus wholesale. Genesco Brands Group, 5% of sales, is licensed wholesale footwear: Levi's expired 2026-05-30 and is being exited, Dockers was re-signed with Authentic Brands through 2031, and a Wrangler license with Kontoor runs to 2030, launching this fall. Genesco manufactures nothing.
2. Why it is mispriced — and the edge case that is not there
The screen flags GCO as a cash cow: 21.0% FCF yield, 0.69x book, net cash, 11 million shares. The first number is an artifact, and that is the most important finding here. Fiscal 2026 operating cash flow of $145.8M versus $87.9M is explained in the MD&A by "the receipt of a $59.3 million income tax refund," a CARES Act carryback from Fiscal 2021 that sat in IRS exam three years and finally paid $60.1M including interest (10-K 2026, Item 7, Liquidity). Strip it out and Fiscal 2026 operating cash flow was roughly $86M against $62.1M of capex, so free cash flow was near $24M, a 6.1% yield, not 21%. The pattern repeats this quarter: GAAP operating income of $3.6M and EPS of $0.32 exist only because of $22.5M of IEEPA tariff refunds, against an adjusted operating loss of $8.3M (Q2 release, Schedule B). The honest edge is therefore structural. Journeys earned $60.5M of operating income in Fiscal 2026 while corporate overhead consumed $43.2M, leaving the whole company $17.3M, a 0.7% margin (10-K 2026, Item 7). Management has now put a $40M to $50M cost program against that overhead, up to $20M this year (Q2 release). The program is roughly the size of corporate expense itself, and it is what a buyer here is actually underwriting.
3. Unit economics and growth
Fiscal 2026 sales rose 4.8% to $2.436B on a 6% comp, gross margin fell 90bp to 46.3% on Schuh promotions and tariffs, and operating margin was 0.7% versus 0.6% (10-K 2026, Item 7). Segment operating income: Journeys $60.5M (4.1% margin, up 210bp), Schuh a $4.5M loss versus $10.2M of profit the prior year, Johnston & Murphy $4.6M (down 45.5%), Brands roughly breakeven, corporate minus $43.2M. In Q2 FY27 sales fell 3% to $529.9M and total comps minus 1%, with Journeys plus 2% for an eighth straight positive quarter and Johnston & Murphy plus 4%, against Schuh minus 9% and e-commerce minus 6% (Q2 release). Adjusted gross margin rose 140bp to 47.2% on less discounting, and adjusted EBITDA was $4.8M versus roughly negative $0.8M a year ago (Schedule B). Fixed costs dominate: selling and administrative expense was 49.0% of sales. Capex guidance of $65M to $70M for Fiscal 2027 runs about $15M above the roughly $52M annualised D&A, so earnings overstate cash generation.
4. Balance sheet and capital allocation
Cash was $57.1M and total debt $15.8M at 2026-08-01 versus $41.0M and $71.0M a year earlier, so $41.3M net cash (Q2 release). The revolver runs to 2031 with $332.5M of commitments, in compliance (10-K 2026, Item 7). Against that sit $568.1M of operating lease liabilities, which is what makes a 0.7% margin dangerous rather than merely disappointing. Equity was $557.0M against a ~$386M market cap. Capital allocation is the weak link: 604,531 shares were bought in Fiscal 2026 at an average $20.79 and 317,503 more so far in Q3, yet cover-page shares outstanding still rose from 10,778,805 to 11,106,973, up 3.0%, because grants outrun repurchases, and only $18.8M of authorisation remains. Insiders own 8.2% as a group, CEO Mimi Vaughn 3.83% (DEF 14A 2025). Director Gregory Sandfort bought 2,958 shares at $33.80 on 2026-07-09, the only open-market purchase in twelve months, with no sales (Form 4, 2026-07-13). The bonus plan charges a 10% cost of capital against net assets, unusually good alignment for a retailer.
5. Management: what they said versus what they did
Bradley Radoff ran a proxy contest and lost decisively on 2026-07-21, his two nominees drawing about 1.03M votes against roughly 8.4M for each company nominee, at a cost of $6.9M in the quarter (8-K 2026-07-22; Q2 release). Finance has churned: Vaughn was interim CFO until Jonathan Collins, from America's Car-Mart and Walmart, took the seat on 2026-08-03, and the Chief Strategy and Digital Officer retires 2026-10-31 (8-Ks 2026-06-29, 2026-08-06). On guidance they have been directionally honest, raising adjusted EPS to the high end of $2.00 to $2.40 and operating income to the high end of $34M to $40M while cutting the comp assumption from plus 1-2% to flat on Schuh weakness (Q2 release, Outlook). Vaughn said the third quarter "is off to a good start with back-to-school and Journeys accelerating to a mid-single-digit comp in August."
6. Valuation
Base, 50%: sales flat near $2.4B, half the cost program reaches the P&L net of reinvestment, Schuh stops losing money, Journeys holds low-single-digit comps. Fiscal 2029 EBIT $55M at 7x plus roughly $60M net cash on 10.2M shares gives about $44. Bear, 30%: the Journeys streak ends, Schuh keeps bleeding, savings are absorbed by wages and occupancy; EBIT settles near $15M at 0.4x book, about $21. Bull, 20%: the full $50M lands, Schuh returns toward the $10.2M it earned in Fiscal 2025, Wrangler scales; EBIT $85M at 8x plus net cash gives about $77. Probability weighted, roughly $44 against $35.81, about 22% upside. Reverse DCF: at a $345M EV, a 25% cash tax rate, a 10% unlevered discount rate, no growth and capex $15M above depreciation, the price implies about $66M of operating income in perpetuity, a 2.8% margin, versus 1.7% guided this year and 0.7% delivered last year. The market is already paying for most of the cost program.
7. Catalysts and timeline
Q3 results in early December 2026 are the first clean read, covering back-to-school with August already at a mid-single-digit Journeys comp. Q4, reported March 2027, generates the year's cash flow and carries first Fiscal 2028 guidance and the first full cost-program scorecard. Wrangler launches this fall. Pzena at 13.0% and Fund 1 Investments at 10.2% put 23% of the register in two value hands (DEF 14A 2025), so renewed activism is live even after Radoff's defeat.
8. Risks and pre-registered kill criteria
- Journeys Group comparable sales negative in two consecutive quarters.
- Schuh Group operating loss for Fiscal 2027 above $15M, or Schuh comparable sales below minus 5% in the Q4 holiday quarter.
- Cover-page shares outstanding above 10.8M on both of the next two 10-Qs, meaning buybacks again fail to shrink the count.
- Fiscal 2028 operating income guided below $50M when issued in March 2027, meaning the cost program is not reaching the P&L. Other risks: $568.1M of lease liabilities under a 0.7% operating margin; all company profit sits in one mall-based teen fashion banner; tax and tariff refunds have flattered two consecutive reported years; wholesale receivables are concentrated, one customer at 22% and another at 13% of the trade balance (10-K 2026, Item 7).
9. Verdict and one-paragraph summary
WATCH, conviction 3. Genesco screens as a 21% free cash flow yield with net cash at 0.69x book, but that yield is an artifact of a one-time $60.1M IRS refund collected in Fiscal 2026, and this quarter's GAAP profit is entirely $22.5M of tariff refunds against an $8.3M adjusted operating loss, so the real trailing yield is about 6%. What is genuinely interesting is structural: Journeys earned $60.5M last year while corporate overhead ate $43.2M, and management has targeted $40M to $50M of cost out by Fiscal 2029, roughly the size of that overhead, with guidance raised twice this year and Journeys running its eighth straight positive comp and accelerating to mid-single digits in August. Against that, Schuh is comping minus 9%, capex runs $15M above depreciation, $568M of leases sit under a 0.7% margin, the share count is up 3.0% despite buybacks, the stock has already risen 35% in six months, and the price already implies that margin roughly doubling and staying there. That is a fair setup, not a cheap one, so wait for the December quarter to show back-to-school converting into profit and for Schuh to stop getting worse.
Research for discussion, not investment advice. Positions and sizing are the reader's decision.